VERTEX PHARMACEUTICALS INC / MA Quarterly Intangible Assets, Net (Excluding Goodwill) in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Intangible Assets, Net (Excluding Goodwill) history and growth rate from Q4 2018 to Q3 2024.
  • Vertex Pharmaceuticals Inc / Ma Intangible Assets, Net (Excluding Goodwill) for the quarter ending September 30, 2024 was $832M, a 37.8% increase year-over-year.
Intangible Assets, Net (Excluding Goodwill), Quarterly (USD)
Intangible Assets, Net (Excluding Goodwill), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $832M +$228M +37.8% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $838M +$234M +38.8% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $835M +$231M +38.3% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $840M +$236M +39.1% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $604M $0 0% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $604M +$217M +56% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $604M +$204M +50.9% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $604M +$204M +50.9% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $604M +$204M +50.9% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $387M -$13M -3.25% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $400M $0 0% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $400M $0 0% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $400M $0 0% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $400M $0 0% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $400M $0 0% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $400M $0 0% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $400M Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $400M Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $400M Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $400M +$400M Dec 31, 2019 10-K 2021-02-11
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.